Published in Clin Microbiol Infect on November 01, 2004
Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev (2012) 1.68
Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection. Emerg Infect Dis (2007) 1.05
Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection. J Infect Dis (2009) 0.97
Healthcare worker occupation and immune response to Pneumocystis jirovecii. Emerg Infect Dis (2009) 0.92
Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression. PLoS One (2013) 0.91
Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens. Clin Microbiol Infect (2009) 0.89
Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein. Int J Infect Dis (2010) 0.85
Vaccine-Induced Immunogenicity and Protection Against Pneumocystis Pneumonia in a Nonhuman Primate Model of HIV and Pneumocystis Coinfection. J Infect Dis (2016) 0.84
Complexity of the MSG gene family of Pneumocystis carinii. BMC Genomics (2009) 0.83
Antibody responses against Pneumocystis jirovecii in health care workers over time. Emerg Infect Dis (2013) 0.80
A Novel CD4(+) T Cell-Dependent Murine Model of Pneumocystis-driven Asthma-like Pathology. Am J Respir Crit Care Med (2016) 0.79
Prevalence of colonization and mitochondrial large subunit rRNA mutation of Pneumocystis jiroveci among Iranian children. Iran J Microbiol (2016) 0.75
Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity. Cell Rep (2017) 0.75
High transient colonization by Pneumocystis jirovecii between mothers and newborn. Eur J Pediatr (2017) 0.75
Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals: Pneumocystis and Beyond. Clin Chest Med (2017) 0.75
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79
Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur J Clin Microbiol Infect Dis (2000) 1.55
[Strongyloidiasis and HTLV-I infection]. Med Clin (Barc) (1999) 1.44
Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi. Antimicrob Agents Chemother (1998) 1.43
Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet (1996) 1.37
Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis (1993) 1.30
Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis (2004) 1.27
Genetic analysis of the chitinase system of Serratia marcescens 2170. J Bacteriol (1997) 1.26
The susceptibility of pure tubulin to high magnetic fields: a magnetic birefringence and x-ray fiber diffraction study. Biophys J (1998) 1.24
Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients. J Infect Dis (1986) 1.20
Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis. Antimicrob Agents Chemother (2000) 1.17
Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections. Ann Trop Med Parasitol (2003) 1.11
Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats. Antimicrob Agents Chemother (2001) 1.11
Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect (2006) 1.09
Amino-terminal domain exchange redirects origin-specific interactions of adeno-associated virus rep78 in vitro. J Virol (2001) 1.09
Predictive value of IgM antibodies to hepatitis C virus in patients with chronic hepatitis C undergoing interferon-alpha therapy. Analysis by two different methods. J Viral Hepat (1994) 1.08
Versatility of choline-binding domain. Microb Drug Resist (1998) 1.08
[A study of the demand for emergency medical care in rural medicine]. Aten Primaria (1989) 1.07
The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms. Ann Trop Med Parasitol (2003) 1.06
Cloning and characterization of two Serratia marcescens genes involved in core lipopolysaccharide biosynthesis. J Bacteriol (1996) 1.05
An easy and quick method for the diagnosis of visceral leishmaniasis in HIV-1-infected individuals. AIDS (1993) 1.02
Identification of a novel enzymatic activity from lactic acid bacteria able to degrade biogenic amines in wine. Appl Microbiol Biotechnol (2013) 1.01
Do sequence repeats play an equivalent role in the choline-binding module of pneumococcal LytA amidase? J Biol Chem (2000) 1.00
In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent. Antimicrob Agents Chemother (1993) 1.00
Pulmonary infection due to Leuconostoc species in a patient with AIDS. Clin Infect Dis (1995) 0.99
Cloning and DNA sequence analysis of a bacteriocin gene of Serratia marcescens. J Gen Microbiol (1992) 0.99
Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur J Clin Microbiol Infect Dis (2004) 0.98
Structural organization of the major autolysin from Streptococcus pneumoniae. J Biol Chem (1996) 0.98
Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain. Clin Microbiol Infect (2005) 0.97
In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats. Antimicrob Agents Chemother (2000) 0.97
Structure and reactivity of surface oxides on Pt(110) during catalytic CO oxidation. Phys Rev Lett (2005) 0.97
Magnetic resonance imaging in the evaluation of inflammatory lesions in muscular and soft tissues: an experimental infection model induced by Candida albicans. Magn Reson Imaging (1999) 0.95
Which lactic acid bacteria are responsible for histamine production in wine? J Appl Microbiol (2005) 0.95
Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis. Antimicrob Agents Chemother (2000) 0.95
Mechanism of colchicine binding to tubulin. Tolerance of substituents in ring C' of biphenyl analogues. Biochemistry (1991) 0.93
Climatic factors and Pneumocystis jiroveci infection in southern Spain. Clin Microbiol Infect (2004) 0.93
A 17 kDa outer-membrane protein (Omp4) from Serratia marcescens confers partial resistance to bacteriocin 28b when expressed in Escherichia coli. Microbiology (1995) 0.93
Polyphasic study of wine Lactobacillus strains: taxonomic implications. Int J Syst Evol Microbiol (2005) 0.93
Development of pneumocystosis animal models: corticosteroid-treated Wistar rat; SCID mouse and nude rat. J Eukaryot Microbiol (1998) 0.92
Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect (2008) 0.92
Bacteriocin 28b from Serratia marcescens N28b: identification of Escherichia coli surface components involved in bacteriocin binding and translocation. Can J Microbiol (1996) 0.90
Molecular characterization of a 17-kDa outer-membrane protein from Klebsiella pneumoniae. Res Microbiol (1997) 0.90
Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones. Antimicrob Agents Chemother (1996) 0.90
Complement component C7 deficiency in a Spanish family. Clin Exp Immunol (2003) 0.90
Microplate assays for in vitro evaluation of anti-Pneumocystis drugs. J Eukaryot Microbiol (1998) 0.89
Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens. Clin Microbiol Infect (2009) 0.89
Chronic myeloid leukemia with expression of ALL-type BCR/ABL transcript: a case-report and review of the literature. Leuk Res (1999) 0.88
A soft X-ray beamline for transmission X-ray microscopy at ALBA. J Synchrotron Radiat (2009) 0.88
Antifungal activities and cytotoxicity studies of six new azasordarins. Antimicrob Agents Chemother (2001) 0.88
Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients. Eur J Clin Microbiol Infect Dis (1995) 0.88
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein binding. Antimicrob Agents Chemother (2001) 0.86
Presence of antibodies to different subunits of replication protein A in autoimmune sera. Proc Natl Acad Sci U S A (1995) 0.85
Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin Exp Immunol (2001) 0.85
Association between human-Pneumocystis infection and small-cell lung carcinoma. Eur J Clin Invest (2004) 0.85
The effect of temperature on the structure of vinblastine-induced polymers of purified tubulin: detection of a reversible conformational change. J Mol Biol (1995) 0.85
Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats. Antimicrob Agents Chemother (2001) 0.85
Residue-specific bioincorporation of non-natural, biologically active amino acids into proteins as possible drug carriers: structure and stability of the per-thiaproline mutant of annexin V. Proc Natl Acad Sci U S A (1998) 0.85
Control of hypertension in patients at high risk of cardiovascular disease. QJM (2005) 0.85
Binding of gossypol to purified tubulin and inhibition of its assembly into microtubules. Eur J Biochem (1986) 0.85
Tubulin structure probed with antibodies to synthetic peptides. Mapping of three major types of limited proteolysis fragments. Biochemistry (1988) 0.84
Contrasting features of insulin dependent diabetes mellitus associated with neuroectodermal defects and classical insulin dependent diabetes mellitus. Acta Paediatr Scand (1988) 0.83
Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients. Clin Microbiol Infect (2007) 0.83
Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease) associated with normal-pressure hydrocephalus Anatomoclinical report of one case. Acta Neurochir (Wien) (1980) 0.83
Epidemiology of Pneumocystis carinii pneumonia in southern Spain. Clin Microbiol Infect (2004) 0.83
Bacteriocin 28b, a chromosomally encoded bacteriocin produced by most Serratia marcescens biotypes. Res Microbiol (1996) 0.83
Cytoplasmic detection of a novel protein containing a nuclear localization sequence by human autoantibodies. Clin Exp Immunol (1997) 0.83
Identification of cation-independent mannose 6-phosphate receptor/insulin-like growth factor type-2 receptor as a novel target of autoantibodies. Immunology (1999) 0.82
E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens. Antimicrob Agents Chemother (1995) 0.82
Protection against bacteriocin 28b in Serratia marcescens is apparently not related to the expression of an immunity gene. Can J Microbiol (1995) 0.82
Trimethoprim-sulfamethoxazole-induced renal tubular acidosis in a patient with AIDS. Clin Infect Dis (1995) 0.82
Acute pancreatitis associated with sodium stibogluconate treatment in a patient with human immunodeficiency virus. Arch Intern Med (1996) 0.81
AIDS in haemophilia patients in Spain. Lancet (1983) 0.81
Polyphasic taxonomy of a novel yeast isolated from antarctic environment; description of Cryptococcus victoriae sp. nov. Syst Appl Microbiol (1999) 0.81
Comparative survey of putrescine production from agmatine deamination in different bacteria. Food Microbiol (2008) 0.81
Radiation effects analysis in a group of interventional radiologists using biological and physical dosimetry methods. Eur J Radiol (2009) 0.81
Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain. Eur J Clin Microbiol Infect Dis (1995) 0.80
Nucleotide sequence of plasmid p4028, a cryptic plasmid from Leuconostoc oenos. Plasmid (1996) 0.80
Pneumocystis carinii pneumonia in heart transplant recipients. Eur J Cardiothorac Surg (2001) 0.80
Soluble class 1 antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol Scand (1990) 0.80